write about abuse and neglect in children and the role of pediareic dentist. write as mds student in simple language
write about abuse and neglect in children and the role of pediareic dentist. write as mds student in simple language
child abuse neglect pediatric dentistry oral findings
role of pediatric dentist in child abuse and neglect oral signs recognition reporting
https://www.dentalcare.com/en-us/ce-courses/ce599/reporting
PMID: 37749962
| Type | Examples |
|---|---|
| Physical Abuse | Hitting, shaking, burning, biting |
| Sexual Abuse | Rape, fondling, exploitation |
| Emotional/Psychological Abuse | Terrorizing, belittling, humiliating |
| Neglect | Failure to meet basic physical, emotional, educational, or medical/dental needs |
Important principle: When the story given by the parent does not match the injury pattern, or when the injury is inconsistent with the child's developmental stage (e.g., a 3-month-old infant cannot "roll off a bed"), abuse should be strongly suspected.
| Aspect | Key Point |
|---|---|
| Why dentists matter | 50-80% of abuse involves the head/face/mouth region |
| Most common oral sign of neglect | Rampant untreated caries, poor hygiene |
| Most suspicious sign of physical abuse | Torn frenulum in non-ambulatory infant; human bite marks |
| Legal role | Mandated reporter - report on "reasonable suspicion," not proof |
| Documentation | Objective, factual, photographed, with child's exact words |
| Reporting timeline | Verbal within 24 hours, written within 48-72 hours |
| Who to contact | Child Protective Services (CPS) / law enforcement |
| Our attitude | Non-accusatory, empathetic, collaborative |
DISCUSS WITH STUDIESTHE POTENTIAL SYSTEMIC ROLE OF DIET IN DENTAL CARIES DEVELOPMENT AND ARREST. WRITE AS MDS STUDENT IN SIMPLE LANGUAGE
diet dental caries development arrest systemic role
PMID: 38794700
vitamin D dental caries children
systemic role diet dental caries development arrest vitamin D calcium phytate Price Weston studies
PMID: 37858104
PMID: 38589811
https://pmc.ncbi.nlm.nih.gov/articles/PMC11124059
sugar free sugars dental caries risk children
Weston Price traditional diet dental caries indigenous populations Price 1939 nutrition physical degeneration caries findings
PMID: 35302414
PMID: 38086176
| Pathway | Mechanism | Example |
|---|---|---|
| Local | Fermentable carbohydrates → acid by oral bacteria → demineralization of enamel | Sucrose → S. mutans → lactic acid → pH drop → enamel loss |
| Systemic | Nutrient deficiencies or excesses affect tooth formation, salivary function, immune defense, and remineralization capacity | Vitamin D deficiency → poor enamel calcification → weaker teeth prone to caries |
"Studies dating back to the early 1900s point to an important systemic role of diet and nutrition, particularly from pasture-raised animal-source foods, in dental caries etiology and arrest. A diet high in calcium, phosphorus, fat-soluble vitamins A and D, and antioxidant vitamin C, as well as low in phytates, may contribute to arrest and reversal of dental caries, particularly in children."
| Study | Year | Design | Key Finding |
|---|---|---|---|
| Mellanby et al. (human) | 1924 | Controlled diet study, institutionalized children | Diet high in Ca, vit D, low phytate → most caries arrested; high phytate → most caries progression |
| Mellanby & Killick (rabbits) | 1926 | Animal experiment | Cod liver oil/egg yolk supplementation → normal tooth calcification; no supplementation → poor calcification |
| Weston A. Price | 1939 | Ethnographic observational | Traditional nutrient-dense diets → low caries; western diet → high caries across multiple populations |
| Moores, Kelly, Moynihan (2022) | 2022 | Systematic Review (J Dent Res) | 64/78 studies show positive link between sugar intake and caries; lower caries when sugar <10% of energy |
| Large et al. (2024) | 2024 | WHO-commissioned Systematic Review, 37 studies | 34/37 studies show sugar-sweetened beverages and high free-sugar foods increase caries risk in children ≤10 years |
| Li et al. (2023) | 2023 | Meta-analysis, 13 studies (BMC Oral Health) | Vitamin D deficiency → 22% higher caries risk; especially in deciduous teeth (68% higher risk) |
| Bahardoust et al. (2024) | 2024 | Systematic Review & Meta-analysis, 11,021 participants | Prenatal vitamin D deficiency → 35% higher odds of dental caries in children; mothers with vit D ≤35 nmol/L at greatest risk |
| Malin, Wang, Khan, McKune (2024) | 2024 | Narrative Review (Nutrients) | Synthesizes early 1900s to present; diet high in Ca, P, vit A, D, C + low phytates → caries arrest; calls for modern reinvestigation |
WRITE AS MDS LEVEL ANSWER ABOUT RELATION OF DIET AND DENTAL CARIES AND DIET COUNSELLING IN SIMPLE WORDS
diet dental caries dietary counseling children prevention
sugars intake dental caries WHO recommendations
dietary counseling caries prevention effectiveness intervention
PMID: 41515284
sugar sweetened beverages dental caries children cariogenicity
dietary habits eating patterns early childhood caries ECC
diet counselling dental caries Stephan curve cariogenic food frequency diet diary dental office evidence based
snacking frequency between meals dental caries risk
https://assets.ctfassets.net/u2qv1tdtdbbu/5vXJvxB1LMlk1GEvAR…
| Factor | Explanation | High Risk Example |
|---|---|---|
| Sugar content | More fermentable sugar = more acid | Candy, fizzy drinks, sweets |
| Frequency of intake | Each exposure = new acid attack | Constant sipping of juice |
| Texture and stickiness | Sticky food stays on teeth longer, prolonging acid attack | Toffees, dried fruits (raisins), biscuits |
| Oral clearance time | How quickly food is washed away by saliva | Liquids clear fast; solids stay longer |
| pH of food itself | Acidic foods also cause direct erosion | Citrus juice, cola drinks |
| Sequence of eating | Ending a meal with cheese or sugar-free gum reduces acid | Cheese after a sugary dessert |
| Finding | Risk Level |
|---|---|
| Sugar exposures >4/day | High |
| Nighttime bottle with sweetened liquid | Very High (ECC risk) |
| Constant sipping of sweetened drinks | Very High |
| Sticky foods between meals | High |
| Meals ending with fruit/sweets | Moderate-High |
| Meals ending with cheese/water | Low/Protective |
| Adequate dairy, vegetables, water | Protective |
| Practice | Benefit |
|---|---|
| End meals with hard cheese | Raises plaque pH, provides Ca²⁺ and PO₄³⁻ |
| Drink plain/fluoridated water | Dilutes sugars, no acid, provides fluoride |
| Chew xylitol gum after meals | Stimulates saliva, inhibits S. mutans |
| Eat structured meals, avoid constant snacking | Limits number of acid attacks per day |
| Include dairy (milk, yoghurt, cheese) | Calcium and phosphate for remineralization |
| Eat crunchy vegetables/fruits | Stimulates saliva, mechanically cleans teeth |
| Adequate vitamin D (sunlight, fish, eggs) | Systemic tooth mineralization, immune defense |
| Topic | Key Point |
|---|---|
| Primary cause | Fermentable carbohydrates → acid → demineralization |
| Most important factor | Frequency of sugar intake, not just amount |
| Critical pH | 5.5 for enamel demineralization |
| Stephan curve | pH drops within minutes; 20-40 min to recover |
| WHO recommendation | Free sugars <10% daily energy; ideally <5% |
| Safe frequency | ≤4 sugar exposures per day |
| Most cariogenic habit | Nighttime bottle with sweetened liquid in infants |
| Most protective food | Hard cheese, plain water, fluoridated water |
| Diet counselling tool | 3-7 day diet diary + analysis |
| Goal of counselling | Behavioral change through specific, achievable goals |
| Systemic factor | Vitamin D deficiency increases caries risk by 22% (Li et al., 2023) |
WRITE ABOUT CONSORT IN SIMPLE LANGUAGE AS MDS LEVEL
CONSORT statement 2010 checklist randomized controlled trial reporting guidelines explanation elaboration
CONSORT statement randomized controlled trials reporting
WRITE ABOUT CONSORT IN SIMPLE LANGUAGE
CONSORT 2025 statement randomized trials reporting guideline
CONSORT 2025 statement 25 item checklist flow diagram RCT reporting what changed from 2010
PMID: 40228499
https://pmc.ncbi.nlm.nih.gov/articles/PMC11996237
"Biased results from poorly designed and reported trials can mislead decision making in health care at all levels, from treatment decisions for a patient to formulation of national health policies."
- Moher et al., CONSORT 2010 Explanation & Elaboration, BMJ
| Version | Year | What Changed |
|---|---|---|
| CONSORT 1.0 | 1996 | First published; initial 21-item checklist |
| CONSORT 2001 | 2001 | Revised to 22 items; stronger emphasis on blinding and allocation concealment |
| CONSORT 2010 | 2010 | Updated to 25 items; added selective outcome reporting, protocol access |
| CONSORT 2025 | 2025 | Updated to 30 items; new section on open science, data sharing, patient involvement, harms |
| Item | What it asks |
|---|---|
| 1 | Title & Abstract - Identify the study as a randomized trial in title; structured abstract with trial design, methods, results, and conclusions |
| 2 | Trial registration - Trial registry name and registration number (e.g., ClinicalTrials.gov, CTRI) |
| 3 | Protocol access - Where the full trial protocol and statistical analysis plan can be read |
| 4 (NEW) | Data sharing - Whether and how de-identified participant data, statistical code, and materials will be shared |
| 5 | Funding & conflicts - Sources of funding; financial and other conflicts of interest of all authors (NEW: now includes conflicts of interest) |
| Item | What it asks |
|---|---|
| 6 | Background and rationale - Scientific background; why the trial is needed; explicit statement of the trial's objectives and hypotheses |
| Item | What it asks | Why it matters |
|---|---|---|
| 7 | Trial design - Parallel, factorial, crossover? Allocation ratio? | Readers need to know the basic structure |
| 8 (NEW) | Patient and public involvement - How patients/public were involved in designing or conducting the trial | Reflects modern participatory research values |
| 9 | Setting - Hospital, clinic, community? Which countries/sites? | Affects generalizability of results |
| 10 | Changes to methods - Any changes made after the trial started, and why | Transparency - post-hoc changes can introduce bias |
| 11 | Participants: eligibility criteria - Inclusion and exclusion criteria | Defines who the results apply to |
| 12 | Site and deliverer eligibility (NEW) - Criteria for sites and healthcare providers delivering the intervention | Important for complex interventions (e.g., surgical trials) |
| 13 | Interventions - Full description of what was done in each group (dose, frequency, duration, who delivered it) | Must be detailed enough for replication |
| 14 | Outcomes - Primary and secondary outcomes; how and when measured | Pre-specified outcomes prevent selective reporting |
| 15 (NEW) | Harms assessment - How harms and unintended effects were assessed and collected | Adverse events must be systematically monitored |
| 16 | Sample size - How the target sample size was calculated; assumptions used | Shows whether the trial was adequately powered |
| 17 | Randomization: sequence generation - How the random sequence was generated (e.g., computer-generated, random number table) | Core to the validity of an RCT |
| 18 | Allocation concealment - Mechanism used to hide the allocation sequence until assignment (e.g., sealed envelopes, central allocation) | Prevents selection bias before randomization |
| 19 | Implementation - Who generated the sequence, who enrolled participants, who assigned interventions | Shows whether the process was truly independent |
| 20 | Blinding - Who was blinded (participants, caregivers, outcome assessors)? How? | Prevents performance and detection bias |
| 21 | Statistical methods - Methods used to compare groups for outcomes; additional analyses | Allows evaluation of analytic choices |
| Item | What it asks |
|---|---|
| 22 | Participant flow - Numbers randomized, received treatment, analyzed for primary outcome, lost to follow-up; (with the Flow Diagram) |
| 23 | Recruitment - Dates of recruitment and follow-up; why the trial ended (if stopped early) |
| 24 | Baseline data - Table showing demographic and clinical characteristics of each group at baseline |
| 25 | Numbers analyzed - Number analyzed for each outcome; whether analysis was intention-to-treat (ITT) or per-protocol |
| 26 | Outcomes and estimation - Results for each primary and secondary outcome (effect size, confidence intervals, p-values) |
| Item | What it asks |
|---|---|
| 27 | Limitations - Risks of bias, imprecision, other sources of potential bias |
| 28 | Generalizability - External validity; to whom can results be applied? |
| 29 | Interpretation - Overall interpretation consistent with the evidence; benefits vs. harms balance |
| 30 | Other information - Any other relevant information not covered elsewhere |
ENROLLMENT
├── Assessed for eligibility (n = ___)
│ ├── Excluded (n = ___)
│ │ ├── Did not meet inclusion criteria (n = ___)
│ │ ├── Declined to participate (n = ___)
│ │ └── Other reasons (n = ___)
│ └── Randomized (n = ___)
|
┌─────────────────────┐
↓ ↓
GROUP A GROUP B
Allocated (n=__) Allocated (n=__)
Received (n=__) Received (n=__)
Did not receive (n=__) Did not receive (n=__)
FOLLOW-UP
Lost to follow-up (n=__) Lost to follow-up (n=__)
Discontinued (n=__) Discontinued (n=__)
ANALYSIS
Analysed (n=__) Analysed (n=__)
Excluded from analysis Excluded from analysis
(n=___, reason) (n=___, reason)
| Change | Details |
|---|---|
| +7 new items | Data sharing, conflicts of interest, patient involvement, site eligibility criteria, harms assessment, and more |
| 3 items revised | Wording clarified for better understanding |
| 1 item deleted | Removed because it was redundant |
| New Open Science section | Groups trial registration, protocol access, data sharing, and conflicts of interest together in one new front section |
| Integration of extensions | Items from CONSORT Harms, CONSORT Outcomes, CONSORT Non-pharmacological Treatments, and TIDieR (intervention description) now integrated directly |
| Patient and Public Involvement (PPI) | New item requiring disclosure of whether patients/public were involved in designing the trial |
| Data sharing | New requirement to state whether raw participant-level data will be publicly shared |
Hopewell S et al. CONSORT 2025 Statement. JAMA. 2025 (PMID: 40228499) "Authors, editors, reviewers, and other potential users should use CONSORT 2025 when writing and evaluating manuscripts of randomized trials to ensure that trial reports are clear and transparent."
| Extension | For What Type of Trial |
|---|---|
| CONSORT Cluster | Cluster randomized trials (e.g., whole schools or clinics are randomized) |
| CONSORT Crossover | Trials where participants receive both treatments in sequence |
| CONSORT Non-inferiority | Trials testing whether a new treatment is "not worse than" an existing one |
| CONSORT Harms | Better reporting of adverse events and side effects |
| CONSORT PRO | Patient-reported outcomes (pain scores, quality of life) |
| CONSORT Non-pharmacological | Behavioral, surgical, or procedure-based interventions |
| CONSORT Pilot/Feasibility | Small preliminary trials to test feasibility |
| TIDieR | Template for Intervention Description and Replication - describes interventions in detail |
| Guideline | Type of Study | Full Form |
|---|---|---|
| CONSORT | Randomized Controlled Trials | Consolidated Standards of Reporting Trials |
| PRISMA | Systematic Reviews & Meta-analyses | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| STROBE | Observational Studies | Strengthening the Reporting of Observational Studies in Epidemiology |
| STARD | Diagnostic Accuracy Studies | Standards for Reporting Diagnostic Accuracy |
| CARE | Case Reports | Case Report guidelines |
| SPIRIT | Trial Protocols (before the trial) | Standard Protocol Items: Recommendations for Interventional Trials |
| Feature | Details |
|---|---|
| Full form | Consolidated Standards of Reporting Trials |
| Purpose | Minimum standards for reporting RCTs transparently |
| First published | 1996 |
| Current version | CONSORT 2025 |
| Number of items | 30 items (CONSORT 2025) |
| Two components | 25-item checklist + flow diagram |
| Applies to | All randomized controlled trials |
| Focus design | Two-group, parallel, individually randomized trials |
| New in 2025 | Open science section, data sharing, PPI, harms, site eligibility |
| Related guideline for protocol | SPIRIT 2025 |
| Website | consort-statement.org |
| Key authors (2025) | Hopewell S, Chan AW, Collins GS et al. |
CONSORT = The "recipe card" that tells you exactly what ingredients must be listed when you serve an RCT to the scientific world - so everyone can see what went in, how it was cooked, and whether it is safe to eat.
EXPLAIN DIET DIARY AND COUNSELLING WITH REFERENCE OF NIKHIL MARWAH ANH SHIBHA TANDON TEXTBOOKS
Nikhil Marwah textbook pediatric dentistry diet diary counselling chapter
https://asset.ejaypee.com/sample-chapters/9789356961012.pdf
Shibha Tandon textbook pediatric dentistry diet counselling diet diary chapter content
https://saspublishers.com/article/8824/download
"The pedodontist is in a unique position to promote good nutrition in his patients and their families as he is treating a disease to which diet contributes dramatically to both etiology and treatment."
| Column | What to Record |
|---|---|
| Time | Exact time of each eating or drinking event |
| Food/Drink | Name and description of every item, including snacks |
| Amount | Household measures (spoons, cups, pieces) |
| Preparation | How it was cooked (fried, boiled, raw) |
| Sugar added | Number of teaspoons of sugar added to tea, porridge, etc. |
| Between meal or meal | Whether it was a proper meal or a between-meal snack |
| Score Range | Interpretation |
|---|---|
| 60-100 | Acceptable diet - counselling not usually required unless patient requests it |
| 56 or less | Diet counselling is indicated and recommended |
| Very low (<40) | High caries activity diet - intensive counselling required |
"The sugar clock must be stressed upon - it explains to parents the importance of abstaining from frequent snacking through the day. This will decrease the amount of time the pH of oral fluids remains below the critical pH (5.2-5.5) and thus reduce demineralization attacks on the tooth surface." - as described in Marwah, Chapter 25
| Instead of... | Suggest... |
|---|---|
| Sweetened juice between meals | Plain water or plain milk |
| Sweet biscuits as a snack | Cheese, peanuts, raw vegetables |
| Bedtime bottle with sweetened milk/juice | Plain water; brush after last feed |
| Toffees and sticky sweets | Fresh fruit (consumed at mealtime) |
| Sweetened cereals for breakfast | Plain oats, egg, whole grain |
| Cola/fizzy drinks | Coconut water, plain buttermilk |
| Topic | Key Point |
|---|---|
| Diet diary duration | 6 days (Marwah); 3-5-7 days (Tandon); include one weekend day |
| 24-hr recall | Taken at first appointment as initial screening |
| Dental Health Diet Score | Score 60-100: acceptable; score ≤56: counselling indicated |
| Sugar clock | Visual tool to show number and timing of acid attacks |
| Number of appointments | Minimum 2 (diary issue + counselling); plus follow-up |
| Key message | Frequency of sugar intake is more important than total amount |
| Most dangerous habit | Bedtime bottle/feed with sweetened liquid |
| Most protective food | Hard cheese, plain water |
| Level of prevention | Primary prevention |
| Critical pH | 5.2-5.5 (Marwah/Tandon); commonly stated as 5.5 |
| Follow-up tool | Repeat 5-day diary + Snyder test + clinical examination |
WRITE PARAMETRIC AND NON PARAMETRIC TESTS ON THE BASIS OF SOBEN PETER AND TEXTBOOK OF CM MARYA IN SIMPLE LANGUAGE
Soben Peter "essentials of preventive community dentistry" parametric non-parametric statistical tests chapter
https://www.oyschst.edu.ng/elib/dashboard/ebooks/59ppcQxO.pd…
CM Marya textbook community dentistry research methodology parametric non-parametric statistical tests t-test chi square Mann Whitney
https://pmc.ncbi.nlm.nih.gov/articles/PMC11506617
Is my data normally distributed (Gaussian) or not?
"Choosing the right test to compare measurements is a bit tricky, as you must choose between two families of tests - parametric and non-parametric."
| Situation | Use |
|---|---|
| Data is normally distributed, continuous (interval/ratio scale), sample ≥ 30 | Parametric test |
| Data is not normally distributed (skewed) | Non-parametric test |
| Data is on an ordinal / ranked scale (e.g., VAS, Likert scale) | Non-parametric test |
| Small sample (n < 30) and normality is uncertain | Non-parametric test (safer choice) |
| Some values are too high or too low to measure | Non-parametric test |
| Categorical / nominal data (yes/no, present/absent) | Non-parametric test (chi-square) |
| Type | When to Use | Example in Dentistry |
|---|---|---|
| Independent (unpaired) t-test | Two separate, unrelated groups | Compare mean DMFT of fluoride group vs. control group |
| Paired t-test | Same subjects measured twice (before and after) | Compare plaque index before and after oral hygiene instruction in same patients |
| One-sample t-test | Compare sample mean to a known population mean | Is our sample's mean salivary pH different from the standard of 7.0? |
t = (Mean1 - Mean2) / Standard Error of Difference between means
F = Variance BETWEEN groups / Variance WITHIN groups
| r Value | Interpretation |
|---|---|
| +1.0 | Perfect positive correlation |
| +0.7 to +0.9 | Strong positive correlation |
| +0.4 to +0.6 | Moderate positive correlation |
| 0 | No correlation |
| -0.4 to -0.6 | Moderate negative correlation |
| -1.0 | Perfect negative correlation |
| Test | Compares | Data Type | Groups |
|---|---|---|---|
| Z-test | Means (large samples) | Continuous, normal | 2 |
| t-test (unpaired) | Means (small samples) | Continuous, normal | 2 independent |
| t-test (paired) | Means (before-after) | Continuous, normal | Same group, 2 time points |
| One-way ANOVA | Means | Continuous, normal | 3 or more independent |
| Two-way ANOVA | Means (two factors) | Continuous, normal | Multiple groups, 2 factors |
| Pearson's r | Correlation | Continuous, normal | - |
χ² = Σ [(O - E)² / E]
df = (r - 1)(c - 1)
| Non-Parametric Test | Parametric Equivalent | When to Use |
|---|---|---|
| Chi-Square (χ²) | Z-test for proportions | Categorical data, 2+ groups, association testing |
| Mann-Whitney U | Independent t-test | 2 independent groups, ordinal/non-normal |
| Wilcoxon Signed-Rank | Paired t-test | Same group, 2 time points, ordinal/non-normal |
| Kruskal-Wallis | One-way ANOVA | 3+ independent groups, ordinal/non-normal |
| Friedman | Repeated-measures ANOVA | Same group, 3+ time points, ordinal/non-normal |
| Spearman's rho (ρ) | Pearson's r | Correlation, ordinal or non-normal data |
| P-value | Interpretation |
|---|---|
| p > 0.05 | Not significant - difference could be due to chance; accept null hypothesis |
| p ≤ 0.05 | Significant - reject null hypothesis; difference is real |
| p ≤ 0.01 | Highly significant |
| p ≤ 0.001 | Very highly significant |
| Error | What it means | Also called | Controlled by |
|---|---|---|---|
| Type I (α) | Rejecting a true null hypothesis (false positive - you conclude there IS a difference when there isn't) | Alpha error | Significance level (α = 0.05) |
| Type II (β) | Accepting a false null hypothesis (false negative - you miss a real difference) | Beta error | Sample size, statistical power |
| Wrong Choice | Consequence |
|---|---|
| Using parametric test for non-Gaussian data (small sample) | P-value becomes inaccurate - misleading conclusions |
| Using parametric test for non-Gaussian data (large sample) | Parametric tests are robust - small effect, can be used cautiously |
| Using non-parametric test for Gaussian data | P-values are slightly too large (conservative) - slightly less power, but acceptable |
WHAT IS YOUR RESEARCH QUESTION?
|
↓
What type of data do you have?
|
┌─────────────────────────────┐
| |
CATEGORICAL CONTINUOUS/ORDINAL
(Yes/No, Male/Female) |
| Is data normally distributed?
↓ / \
Chi-square test YES NO
(non-parametric) | |
How many groups? How many groups?
/ \ / \
2 3+ 2 3+
| | | |
t-test ANOVA Mann-Whitney Kruskal-Wallis
(independent)
| |
(same group?) (same group?)
| |
Paired t-test Wilcoxon Signed-Rank
CORRELATION?
- Normal data → Pearson's r
- Ordinal/non-normal → Spearman's rho
| Research Question | Data Type | Appropriate Test |
|---|---|---|
| Compare mean DMFT between fluoride varnish and control group (n=40 each) | Continuous, normal | Independent t-test |
| Compare plaque scores before and after oral hygiene instruction in same 20 patients | Continuous, normal | Paired t-test |
| Compare mean OHI-S across three income groups (n=100 each) | Continuous, normal | One-way ANOVA |
| Compare pain VAS scores (0-10) between two local anesthetics | Ordinal | Mann-Whitney U |
| Compare pain scores at 24h, 48h, 72h after extraction (same patients) | Ordinal | Friedman test |
| Is caries prevalence different between urban and rural children? | Categorical | Chi-square test |
| Relationship between sugar intake and DMFT (normal data) | Continuous, normal | Pearson's r |
| Relationship between Likert-scale OHI knowledge score and gingival index | Ordinal | Spearman's rho |
| Feature | Parametric Tests | Non-Parametric Tests |
|---|---|---|
| Assumption | Normal (Gaussian) distribution | No distribution assumption |
| Data type | Continuous (interval/ratio) | Ordinal, nominal, or non-normal |
| Sample size | Larger (ideally ≥30) | Any size, especially small |
| Central measure | Mean | Median or ranks |
| Statistical power | Higher (more powerful) | Slightly lower |
| Robustness | Less robust to violations | More robust |
| Examples | t-test, ANOVA, Pearson's r | Chi-square, Mann-Whitney, Wilcoxon, Kruskal-Wallis, Spearman's rho |